Monoclonal Antibody hA20 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

Last updated: February 16, 2012
Sponsor: Immunomedics, Inc.
Overall Status: Active - Recruiting

Phase

1

Condition

Lymphoma

Treatment

N/A

Clinical Study ID

NCT00112970
CDR0000425383
IM-T-HA20-01
  • Ages > 18
  • Both

Study Design

Total Participants: 28
Study Start date:
February 01, 2004
Estimated Completion Date:

Connect with a study center

  • New York Weill Cornell Cancer Center at Cornell University

    New York, New York 10021
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.